Where does Scivita Medical Technology Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Scivita Medical Technology Co., Ltd. ranks #42,845 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Scivita Medical Technology Co., Ltd. hold?

Scivita Medical Technology Co., Ltd. holds 6 US utility patents granted between 2022 and 2025, spanning 6 technology areas.

What is Scivita Medical Technology Co., Ltd.'s Innovation Score?

Scivita Medical Technology Co., Ltd. has an Innovation Score of 40.1 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Scivita Medical Technology Co., Ltd. focus on?

Scivita Medical Technology Co., Ltd.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 4 patents, ranking #3,645 of 7,127 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Scivita Medical Technology Co., Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Scivita Medical Technology Co., Ltd..

What does claim depth mean for Scivita Medical Technology Co., Ltd.'s patents?

Scivita Medical Technology Co., Ltd.'s patents average 7.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Scivita Medical Technology Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Scivita Medical Technology Co., Ltd.

USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Scivita ranks #42,845 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.

#42,845
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.1/100): 7.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R42845 · Foreign Corporation #42,845 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #42,845/49,997
PHOTO-FINISH Science AND…
CPC-NARROW A61B · 6 areas
INNOV-PAR 40.1/100
CLAIMS-SPARSE 7.8 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2022–2025 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Science AND INNOVATIONS—NUCLEAR Industry Scientific Development, Private Enterprise (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Scivita’s 40.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (17%) Velocity 20.0 pts (50%) Breadth 8.7 pts (22%) Claim depth 4.7 pts (12%)

Qualcomm Incorporated · highest

85
Scivita Medical… · this assignee

40
3D Lighting… · lowest

7

What this shows Scivita's Innovation Score is 40.1/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Scivita?

Each dot is one of Scivita’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Scivita’s own 7.8 claims/patent is at or below the 11.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Scivita vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Scivita's grants concentrate

Scivita Medical Technology Co., Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 66.7% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2022. By volume, Scivita sits between Science AND INNOVATIONS—NUCLEAR Industry Scientific Development, Private Enterprise and Seal AND Pack Co., Ltd.

Scivita's three-year grant acceleration

Scivita Medical Technology Co., Ltd. shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Science AND Innov…

6
Science Cadets

6
Science Research…

6
Scientific Protei…

6
Scorpion OIL Tools

6
Scott Sports

6
Sea-train Express—

6
Seal AND Pack

6
Scivita Medical T… ◀

6

What this shows Scivita holds 6 patents at rank #42,767, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Scivita

By rank, the assignees closest to #42,767 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Scivita's primary technology class.

Scivita's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table

Scivita Medical Technology Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2022	1	16.7%
2023	2	33.3%
2024	2	33.3%
2025partial year	1	16.7%

Which technologies does Scivita Medical Technology Co., Ltd. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 4

H04N - Pictorial Communication, e.g. Television 3

G06T - Image Data Processing OR Generation, IN General 2

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Scivita Medical Technology Co., Ltd.'s patent record in context - here's where to go next.

Scivita Medical Technology Co., Ltd.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 66.7% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #42,845 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Scivita Medical Technology Co., Ltd. against Science AND INNOVATIONS—NUCLEAR Industry Scientific Development, Private Enterprise, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.